In Silico Approaches to Naturally Existing Chalcones and Flavonoids on Mao Inhibitory Action: A Boon to CNS Drug Discovery
- Authors: Arafa Musa1, Della Grace Thomas Parambi2, Mutairah Shaker Alshammari3, Rania Bakr4, Mohammed A. Abdelgawad5, Dibya Sundar Panda6, Manoj Kumar Sachidanandan7, Vaishnav Bhaskar8, Leena K. Pappachen9, Bijo Mathew10
-
View Affiliations Hide Affiliations1 Department of Pharmacognosy, College of Pharmacy, Jouf University, Sakaka, Al Jouf, 72341, Saudi Arabia 2 Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Al Jouf, 72341, Saudi Arabia 3 Department of Pharmaceutical Analytical Chemistry, Jouf University, Sakaka, Al Jouf, 72341, Saudi Arabia 4 Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Al Jouf, 72341, Saudi Arabia 5 Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Al Jouf, 72341, Saudi Arabia 6 Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka, Al Jouf, 72341, Saudi Arabia 7 Department of Oral and maxillofacial surgery and diagnostics, College of Dentistry, Hail University, Hail Province, 2440, Saudi Arabia 8 Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Amrita Health Science Campus, Kochi 682 041, India 9 Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Amrita Health Science Campus, Kochi-682 041, India 10 Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Amrita Health Science Campus, Kochi-682 041, India
- Source: Flavonoids and Phenolics , pp 173-195
- Publication Date: November 2022
- Language: English
In Silico Approaches to Naturally Existing Chalcones and Flavonoids on Mao Inhibitory Action: A Boon to CNS Drug Discovery, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9789815079098/chapter-6-1.gif
In silico studies or computer-aided drug design (CADD) have led to advancement in drug discovery and development of neurodegenerative disorders (NDDs) and neuropsychiatric disorders. CADD is being increasingly used by universities and industries and provides a clear understanding of molecular interactions. Predicting molecular interactions provides relevant information to extract the potential of bioactive compounds. At present, more interest is on natural entities as therapeutic agents with different heterocyclic categories. Various heterocyclic structures are suggested to show MAO (monoamine oxidase) inhibitory activity by CADD and preclinical studies. Among these, chalcones and flavonoids play a major role in MAO inhibitory action because of the phenolic ring. In this chapter, we discuss in silico studies of natural chalcones and flavonoids with MAO inhibitory by considering the complexity of the brain and the multifactorial nature of neurodegenerative disorders. These in silico studies prove that phytoconstituents from herbal medicine with therapeutic properties can serve as lead drug molecules for the treatment of NDDs.
-
From This Site
/content/books/9789815079098.chapter-6dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
